Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method and apparatus for using service capability information for user plane location
Wire catalyst for hydrogenation/dehydrogenation reaction and manufacturing method therefor
Methods for increasing efficacy of FOLR1 cancer therapy
Delivery of captions, content advisory and other data through digital interface
System and apparatus for control of published content
Communication device
Portable, single member housing cord protector
  Randomly Featured Patents
G-protein-conjugated receptor agonist
Method and system for dynamically sharing user interface displays among a plurality of application program
System and method for MRI-guided cryosurgery
Computer front bezel
Checkerboard color filter providing tolerance
Process for producing toner
Process of manufacturing a friction ring for use in a clutch or brake
Methods for forming area-efficient scan chains in integrated circuits, and integrated circuits embodying the same
Detection of inflection point in secondary-battery charging process by matching voltage response to first derivative of battery's characteristic curve
Dental prosthesis